Mirion Technologies’s Return On Capital Employed Overview

According to Benzinga Pro data, during Q1, Mirion Technologies (NYSE:MIR) posted sales of $182.10 million. Earnings were up…

According to Benzinga Pro data, during Q1, Mirion Technologies (NYSE:MIR) posted sales of $182.10 million. Earnings were up 73.14%, but Mirion Technologies still reported an overall loss of $42.90 million. In Q4, Mirion Technologies brought in $217.90 million in sales but lost $159.70 million in earnings.

What Is Return On Capital Employed?

Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q1, Mirion Technologies posted an ROCE of -0.03%.

It is important to keep in mind that ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company’s recent performance, but does not account for factors that could affect earnings and sales in the near future.

ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows Mirion Technologies is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth.

For Mirion Technologies, a negative ROCE ratio of -0.03% suggests that management may not be effectively allocating their capital. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns; poor capital allocation can be a leech on the performance of a company over time.

Analyst Predictions

Mirion Technologies reported Q1 earnings per share at $0.06/share, which beat analyst predictions of $0.05/share.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Body and Mind’s Q2 Revenue Flat YoY, Narrows Loss By 94%

Body and Mind announced on Tuesday its financial results for the second quarter of fiscal year 2024 ended Jan. 31, 2024, revealing a 94% year-over-year drop in net loss. The company said that during the quarter it has entered into a definitive agreement to divest its Nevada cultivation and production operations for a total consideration of $2 million to fund its projects in Illinois and New Jersey. According to CEO Michael Mills these two markets "continue to be underserved and offer significant opportunities for revenue growth as we expand our brand and bring our skilled teams to these new markets." "The most recent quarter reflects our work to improve financial performance, improve margins and streamline our operations to support building our operations in Illinois and New Jersey," Mills said. "Nevada's wholesale pricing challenges and wholesale tax structure made it difficult to see the Company's Nevada operations generating sufficient profits over the long term when compared with the opportunity presented by taking the proceeds from Nevada's sale and continuing to build on our Illinois and New Jersey opportunities."

BMMJ

Read More

The Good Shroom Reports Its First Profitable Quarter, Revenue Grows 144% YoY

The Good Shroom Co Inc. (TSXV:MUSH), which owns and operates a portfolio of brands that include traditional cannabis products as well as mushroom-based wellness beverages, announced it's first profit since commencement of operations and released its financial results for the quarter ended April 30, 2023, revealing net revenue of CA$1 million (

TSXV:MUSH